PRU vs TNYA · rev $31.19B vs rev $1.3M
PRU (PRU) versus Tenaya Therapeutics Inc (TNYA) — a side-by-side from cached financials, not a winner call.
PRU (PRU) common stock.
Tenaya Therapeutics Inc (TNYA) is a biotechnology company listed on NASDAQ.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
Latest reported TNYA revenue for 2026-06-30 was $1.3M. Net income was -$62.7M. TNYA currently screens at market cap $156.0M.
PRU currently screens at market cap $0. TNYA currently screens at market cap $156.0M.
Not investment advice. Open the PRU and TNYA stock pages for the full models.
Not investment advice.